Table of Contents

2019-2024 Global Oral Antidiabetic Agents Market Report (Status and Outlook)

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oral Antidiabetic Agents Market Size 2014-2024
2.1.2 Oral Antidiabetic Agents Market Size CAGR by Region
2.2 Oral Antidiabetic Agents Segment by Type
2.2.1 Sulfonylureas
2.2.2 Meglitinides
2.2.3 Biguanides
2.2.4 Thiazolidinediones
2.2.5 Alpha-glucosidase Inhibitors
2.3 Oral Antidiabetic Agents Market Size by Type
2.3.1 Global Oral Antidiabetic Agents Market Size Market Share by Type (2014-2019)
2.3.2 Global Oral Antidiabetic Agents Market Size Growth Rate by Type (2014-2019)
2.4 Oral Antidiabetic Agents Segment by Application
2.4.1 Home Use
2.4.2 Medical Institutions
2.4.3 Others
2.5 Oral Antidiabetic Agents Market Size by Application
2.5.1 Global Oral Antidiabetic Agents Market Size Market Share by Application (2014-2019)
2.5.2 Global Oral Antidiabetic Agents Market Size Growth Rate by Application (2014-2019)

3 Global Oral Antidiabetic Agents by Players
3.1 Global Oral Antidiabetic Agents Market Size Market Share by Players
3.1.1 Global Oral Antidiabetic Agents Market Size by Players (2017-2019)
3.1.2 Global Oral Antidiabetic Agents Market Size Market Share by Players (2017-2019)
3.2 Global Oral Antidiabetic Agents Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Oral Antidiabetic Agents by Regions
4.1 Oral Antidiabetic Agents Market Size by Regions
4.2 Americas Oral Antidiabetic Agents Market Size Growth
4.3 APAC Oral Antidiabetic Agents Market Size Growth
4.4 Europe Oral Antidiabetic Agents Market Size Growth
4.5 Middle East & Africa Oral Antidiabetic Agents Market Size Growth

5 Americas
5.1 Americas Oral Antidiabetic Agents Market Size by Countries
5.2 Americas Oral Antidiabetic Agents Market Size by Type
5.3 Americas Oral Antidiabetic Agents Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Oral Antidiabetic Agents Market Size by Countries
6.2 APAC Oral Antidiabetic Agents Market Size by Type
6.3 APAC Oral Antidiabetic Agents Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Oral Antidiabetic Agents by Countries
7.2 Europe Oral Antidiabetic Agents Market Size by Type
7.3 Europe Oral Antidiabetic Agents Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Oral Antidiabetic Agents by Countries
8.2 Middle East & Africa Oral Antidiabetic Agents Market Size by Type
8.3 Middle East & Africa Oral Antidiabetic Agents Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Oral Antidiabetic Agents Market Forecast
10.1 Global Oral Antidiabetic Agents Market Size Forecast (2019-2024)
10.2 Global Oral Antidiabetic Agents Forecast by Regions
10.2.1 Global Oral Antidiabetic Agents Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Oral Antidiabetic Agents Forecast by Type
10.8 Global Oral Antidiabetic Agents Forecast by Application

11 Key Players Analysis
11.1 Novo Nordisk
11.1.1 Company Details
11.1.2 Oral Antidiabetic Agents Product Offered
11.1.3 Novo Nordisk Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Novo Nordisk News
11.2 Eli Lilly
11.2.1 Company Details
11.2.2 Oral Antidiabetic Agents Product Offered
11.2.3 Eli Lilly Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Eli Lilly News
11.3 Sanofi
11.3.1 Company Details
11.3.2 Oral Antidiabetic Agents Product Offered
11.3.3 Sanofi Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Sanofi News
11.4 Roche
11.4.1 Company Details
11.4.2 Oral Antidiabetic Agents Product Offered
11.4.3 Roche Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Roche News
11.5 Teva
11.5.1 Company Details
11.5.2 Oral Antidiabetic Agents Product Offered
11.5.3 Teva Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 Teva News
11.6 AstraZeneca
11.6.1 Company Details
11.6.2 Oral Antidiabetic Agents Product Offered
11.6.3 AstraZeneca Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 AstraZeneca News
11.7 Wockhardt UK
11.7.1 Company Details
11.7.2 Oral Antidiabetic Agents Product Offered
11.7.3 Wockhardt UK Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Wockhardt UK News
11.8 Merck
11.8.1 Company Details
11.8.2 Oral Antidiabetic Agents Product Offered
11.8.3 Merck Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 Merck News
11.9 Pfizer
11.9.1 Company Details
11.9.2 Oral Antidiabetic Agents Product Offered
11.9.3 Pfizer Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 Pfizer News
11.10 Cipla
11.10.1 Company Details
11.10.2 Oral Antidiabetic Agents Product Offered
11.10.3 Cipla Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 Cipla News

12 Research Findings and Conclusion